Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 113

1.

Morphine inhibits CD8+ T cell-mediated, noncytolytic, anti-HIV activity in latently infected immune cells.

Wang X, Tan N, Douglas SD, Zhang T, Wang YJ, Ho WZ.

J Leukoc Biol. 2005 Sep;78(3):772-6. Epub 2005 Jul 6.

2.

Natural killer cell inhibits human immunodeficiency virus replication in chronically infected immune cells.

Zhang T, Li Y, Wang YJ, Wang X, Young M, Douglas SD, Ho WZ.

Antiviral Res. 2007 Feb;73(2):132-9. Epub 2006 Sep 12.

PMID:
16997390
3.

CD8+ T cell-mediated suppressive activity inhibits HIV-1 after virus entry with kinetics indicating effects on virus gene expression.

Tomaras GD, Lacey SF, McDanal CB, Ferrari G, Weinhold KJ, Greenberg ML.

Proc Natl Acad Sci U S A. 2000 Mar 28;97(7):3503-8.

5.
6.

Productive human immunodeficiency virus type 1 infection in peripheral blood predominantly takes place in CD4/CD8 double-negative T lymphocytes.

Kaiser P, Joos B, Niederöst B, Weber R, Günthard HF, Fischer M.

J Virol. 2007 Sep;81(18):9693-706. Epub 2007 Jul 3.

7.

Antigen-specific beta-chemokine production and CD8 T-cell noncytotoxic antiviral activity in HIV-2-infected individuals.

Ahmed RK, Norrgren H, da Silva Z, Blaxhult A, Fredriksson EL, Biberfeld G, Andersson S, Thorstensson R.

Scand J Immunol. 2005 Jan;61(1):63-71.

8.

CD8+ cell-derived anti-human immunodeficiency virus inhibitory factor.

Barker E.

J Infect Dis. 1999 May;179 Suppl 3:S485-8. Review.

9.
10.

Human immunodeficiency virus interactions with CD8+ T lymphocytes.

Saksena NK, Wu JQ, Potter SJ, Wilkinson J, Wang B.

Curr HIV Res. 2008 Jan;6(1):1-9. Review.

PMID:
18288969
11.

CD8+ T cell mediated noncytolytic inhibition of human immunodeficiency virus type I.

Tomaras GD, Greenberg ML.

Front Biosci. 2001 Mar 1;6:D575-98. Review.

PMID:
11229882
12.

HIV-1-specific cytotoxicity is preferentially mediated by a subset of CD8(+) T cells producing both interferon-gamma and tumor necrosis factor-alpha.

Lichterfeld M, Yu XG, Waring MT, Mui SK, Johnston MN, Cohen D, Addo MM, Zaunders J, Alter G, Pae E, Strick D, Allen TM, Rosenberg ES, Walker BD, Altfeld M.

Blood. 2004 Jul 15;104(2):487-94. Epub 2004 Apr 1.

13.

The CD8+ cell noncytotoxic anti-HIV response can be blocked by protease inhibitors.

Mackewicz CE, Craik CS, Levy JA.

Proc Natl Acad Sci U S A. 2003 Mar 18;100(6):3433-8. Epub 2003 Mar 6.

14.
15.

IL-7 and the HIV Tat protein act synergistically to down-regulate CD127 expression on CD8 T cells.

Faller E, Kakal J, Kumar R, Macpherson P.

Int Immunol. 2009 Mar;21(3):203-16. doi: 10.1093/intimm/dxn140. Epub 2009 Jan 15.

16.

An IL-15 dependent CD8 T cell response to selected HIV epitopes is related to viral control in early-treated HIV-infected subjects.

D'Offizi G, Gioia C, Corpolongo A, Martini F, Paganelli R, Volpi I, Sacchi A, Tozzi V, Narciso P, Poccia F.

Int J Immunopathol Pharmacol. 2007 Jul-Sep;20(3):473-85.

PMID:
17880761
17.

Derivation of herpesvirus saimiri-transformed CD8+ T cell lines with noncytotoxic anti-HIV activity.

Mackewicz CE, Orque R, Jung J, Levy JA.

Clin Immunol Immunopathol. 1997 Mar;82(3):274-81.

PMID:
9073551
18.
19.

Substance P enhances HIV-1 replication in latently infected human immune cells.

Li Y, Douglas SD, Song L, Sun S, Ho WZ.

J Neuroimmunol. 2001 Dec 3;121(1-2):67-75.

PMID:
11730941
20.

CD8+ T cell depletion amplifies hepatitis C virus replication in peripheral blood mononuclear cells.

Li Y, Wang X, Douglas SD, Metzger DS, Woody G, Zhang T, Song L, Ho WZ.

J Infect Dis. 2005 Sep 15;192(6):1093-101. Epub 2005 Aug 10.

Items per page

Supplemental Content

Write to the Help Desk